Search
Home
News
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
AI
Innovation
Cybersecurity
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Analytics
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Home
News
Fortune 500
Fortune 500
Fortune Global 500
Fortune 500 Europe
Fortune China 500
Fortune SEA 500
Great Place To Work
Tech
Tech
AI
Innovation
Cybersecurity
Finance
Finance
Personal Finance
Real Estate
Economy
Investing
Banking
Crypto
Leadership
Leadership
Success
Future Of Work
Workplace Culture
C-Suite
CEO Initiative
Lifestyle
Lifestyle
Arts & Entertainment
Travel & Leisure
Health
Well
Education
Rankings
Rankings
Analytics
Multimedia
Multimedia
Live Media
Magazine
Newsletters
Video
Podcasts
Asia
Europe
Analytics
home
home
obesity
obesity
Page 6 of 12
Retail
Novo Nordisk faces first real test as Eli Lilly wins approval for a weight loss-aiding drug—and it’s nearly $300 cheaper than Wegovy
By
Ryan Hogg
November 9, 2023
Health
Medications aren’t required to be tested in people with obesity. Here’s why that’s a problem
By
Jonel Aleccia
and
The Associated Press
November 7, 2023
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By
Ryan Hogg
November 6, 2023
Health
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By
Ryan Hogg
November 2, 2023
Life
Your number of daily steps matter—but so does your speed. Walking at this pace may help you live longer, new research reveals
By
Erin Prater
October 27, 2023
Health
New weight-loss blockbuster drug emerges from study showing Mounjaro helps people lose 25% of their body weight or 60 pounds on average
By
Jonel Aleccia
and
The Associated Press
October 15, 2023
Lifestyle
Weight-loss-aiding drugs Ozempic and Wegovy are dampening food sales, top Walmart exec says
By
Chloe Taylor
October 5, 2023
Health
Ozempic and Wegovy ‘significantly’ improve blood sugar and weight for the long-term, new study suggests
By
Erin Prater
October 2, 2023
Tech
TikTok’s hidden ‘Ozempic economy,’ where weight-loss influencers trade referrals for drug discounts and cash
By
Alexandra Sternlicht
September 19, 2023
Retail
Wegovy maker Novo Nordisk leapfrogs LVMH to become Europe’s most valuable company after it takes its ‘miracle’ weight loss drug to the U.K.
By
Prarthana Prakash
September 5, 2023
Health
If you take Wegovy or Ozempic, you may not want to go under anesthesia—there could be life-threatening complications
By
Jonel Aleccia
and
The Associated Press
August 13, 2023
Health
A pharma company helping Elon Musk shed weight is now worth more than the entire economy of Denmark
By
Prarthana Prakash
August 11, 2023
Health
Popular weight-loss injectable Wegovy cuts risk of heart attack and stroke by 20%, company says
By
Erin Prater
August 8, 2023
Health
From Bezos and Zuckerberg getting buff to the celebrity Ozempic craze, ‘fatphobia’ in the workplace is more rampant than ever
By
Paige Hagy
August 1, 2023
Magazine
Novo Nordisk developed Ozempic and started a weight-loss revolution. Its next moonshot is eliminating obesity altogether
By
Vivienne Walt
July 31, 2023
Most Popular
C-Suite
'I’ve spent my entire life making YouTube videos. They’ve spent their entire lives helping people': MrBeast teams with...
By
James Pollard
and
The Associated Press
Banking
Suddenly, the Fed interest rate cut in December looks like it is very much back on the table
By
Jim Edwards
Travel & Leisure
Transportation chief offers advice to increasingly angry Americans: ‘Let’s maybe go back to an era where we didn’t wear...
By
Jason Ma